CNPEX
Price
$72.30
Change
-$0.37 (-0.51%)
Updated
Jul 2 closing price
Net Assets
171.51B
NFACX
Price
$35.83
Change
-$0.23 (-0.64%)
Updated
Jul 2 closing price
Net Assets
829.71M
Interact to see
Advertisement

CNPEX vs NFACX

CNPEX vs NFACX Comparison Chart in %
View a ticker or compare two or three
VS
CNPEX vs. NFACX commentary
Jul 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPEX is a Hold and NFACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPEX has more cash in the bank: 172B vs. NFACX (830M). CNPEX pays higher dividends than NFACX: CNPEX (0.74) vs NFACX (0.00). CNPEX was incepted earlier than NFACX: CNPEX (24 years) vs NFACX (16 years). NFACX (1.96) is less costly to investors than CNPEX (0.98). NFACX is a more actively managed with annual turnover of: 79.00 vs. CNPEX (23.00). CNPEX has a lower initial minimum investment than NFACX: CNPEX (250) vs NFACX (1000). CNPEX annual gain was more profitable for investors over the last year : 8.00 vs. NFACX (4.11). CNPEX return over 5 years is better than : 12.91 vs. NFACX (0.38).
CNPEXNFACXCNPEX / NFACX
Total Expense Ratio0.981.8752%
Annual Report Gross Expense Ratio0.981.9650%
Fund Existence24 years16 years-
Gain YTD5.9506.92386%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets172B830M20,723%
Annual Yield % from dividends0.740.00-
Returns for 1 year8.004.11194%
Returns for 3 years36.9249.0875%
Returns for 5 years12.910.383,399%
Returns for 10 years117.37-27.46-427%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OIERX28.230.31
+1.11%
JPMorgan Equity Income R5
MSTSX11.820.09
+0.77%
Morningstar Global Opportunistic Equity
BCSKX11.440.08
+0.70%
BlackRock Commodity Strategies K
JLCAX23.55-0.06
-0.25%
JPMorgan US Large Cap Core Plus A
DSMDX24.11-0.64
-2.59%
Driehaus Small/Mid Cap Growth